88 related articles for article (PubMed ID: 20734391)
1. Oncolytic designer host defense peptide suppresses growth of human liposarcoma.
Steinstraesser L; Schubert C; Hauk J; Becerikli M; Stricker I; Koeller M; Hatt H; von Duering M; Shai Y; Steinau HU; Jacobsen F
Int J Cancer; 2011 Jun; 128(12):2994-3004. PubMed ID: 20734391
[TBL] [Abstract][Full Text] [Related]
2. Suppression of soft tissue sarcoma growth by a host defense-like lytic peptide.
Steinstraesser L; Hauk J; Schubert C; Al-Benna S; Stricker I; Hatt H; Shai Y; Steinau HU; Jacobsen F
PLoS One; 2011 Mar; 6(3):e18321. PubMed ID: 21483840
[TBL] [Abstract][Full Text] [Related]
3. Genotoxic and cytotoxic activity of host defense peptides against human soft tissue sarcoma in an in vitro model.
Steinstraesser L; Hauk J; Al-Benna S; Langer S; Ring A; Kesting M; Sudhoff H; Becerikli M; Käfferlein H; Jacobsen F
Drug Chem Toxicol; 2012 Jan; 35(1):96-103. PubMed ID: 21851146
[TBL] [Abstract][Full Text] [Related]
4. An armed oncolytic adenovirus ZD55-IL-24 combined with ADM or DDP demonstrated enhanced antitumor effect in lung cancer.
Zhong S; Yu D; Wang Y; Qiu S; Wu S; Liu XY
Acta Oncol; 2010; 49(1):91-9. PubMed ID: 19734998
[TBL] [Abstract][Full Text] [Related]
5. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
6. Suppression of human solid tumor growth in mice by intratumor and systemic inoculation of histidine-rich and pH-dependent host defense-like lytic peptides.
Makovitzki A; Fink A; Shai Y
Cancer Res; 2009 Apr; 69(8):3458-63. PubMed ID: 19351852
[TBL] [Abstract][Full Text] [Related]
7. Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.
Liu C; Sarkaria JN; Petell CA; Paraskevakou G; Zollman PJ; Schroeder M; Carlson B; Decker PA; Wu W; James CD; Russell SJ; Galanis E
Clin Cancer Res; 2007 Dec; 13(23):7155-65. PubMed ID: 18056196
[TBL] [Abstract][Full Text] [Related]
8. [Construction of a new oncolytic virus oHSV2hGM-CSF and its anti-tumor effects].
Shi GL; Zhuang XF; Han XP; Li J; Zhang Y; Zhang SR; Liu BL
Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):89-95. PubMed ID: 22780924
[TBL] [Abstract][Full Text] [Related]
9. Role of glycosylation in the anticancer activity of antibacterial peptides against breast cancer cells.
Han YY; Liu HY; Han DJ; Zong XC; Zhang SQ; Chen YQ
Biochem Pharmacol; 2013 Nov; 86(9):1254-62. PubMed ID: 23962446
[TBL] [Abstract][Full Text] [Related]
10. A novel genetically modified oncolytic vaccinia virus in experimental models is effective against a wide range of human cancers.
Haddad D; Chen N; Zhang Q; Chen CH; Yu YA; Gonzalez L; Aguilar J; Li P; Wong J; Szalay AA; Fong Y
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S665-74. PubMed ID: 22258815
[TBL] [Abstract][Full Text] [Related]
11. Oncolytic virotherapy for human bone and soft tissue sarcomas using live attenuated poliovirus.
Atsumi S; Matsumine A; Toyoda H; Niimi R; Iino T; Nakamura T; Matsubara T; Asanuma K; Komada Y; Uchida A; Sudo A
Int J Oncol; 2012 Sep; 41(3):893-902. PubMed ID: 22692919
[TBL] [Abstract][Full Text] [Related]
12. Newcastle diseases virus strain V4UPM displayed oncolytic ability against experimental human malignant glioma.
Zulkifli MM; Ibrahim R; Ali AM; Aini I; Jaafar H; Hilda SS; Alitheen NB; Abdullah JM
Neurol Res; 2009 Feb; 31(1):3-10. PubMed ID: 18937888
[TBL] [Abstract][Full Text] [Related]
13. Oncolytic reovirus combined with trastuzumab enhances antitumor efficacy through TRAIL signaling in human HER2-positive gastric cancer cells.
Hamano S; Mori Y; Aoyama M; Kataoka H; Tanaka M; Ebi M; Kubota E; Mizoshita T; Tanida S; Johnston RN; Asai K; Joh T
Cancer Lett; 2015 Jan; 356(2 Pt B):846-54. PubMed ID: 25444894
[TBL] [Abstract][Full Text] [Related]
14. [Antitumor and antimetastatic effect of antimicrobial peptide conjugated with tumor homing peptide TMTP1 on the transplanted prostate cancer and gastric cancer in nude mice].
Ma XY; Li S; Luo DF; Liu RH; Lu YP; Wang SX; Ma D; Xi L
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):737-41. PubMed ID: 24378093
[TBL] [Abstract][Full Text] [Related]
15. Anticancer activity of oncolytic adenoviruses carrying p53 is augmented by 11R in gallbladder cancer cell lines in vitro and in vivo.
Wang J; Yu Y; Yan Z; Hu Z; Li L; Li J; Jiang X; Qian Q
Oncol Rep; 2013 Aug; 30(2):833-41. PubMed ID: 23727990
[TBL] [Abstract][Full Text] [Related]
16. Suppression of human prostate tumor growth in mice by a cytolytic D-, L-amino Acid Peptide: membrane lysis, increased necrosis, and inhibition of prostate-specific antigen secretion.
Papo N; Braunstein A; Eshhar Z; Shai Y
Cancer Res; 2004 Aug; 64(16):5779-86. PubMed ID: 15313920
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of a novel recombinant mutant human tumor necrosis factor-related apoptosis-inducing ligand.
Fang F; Wang AP; Yang SF
Acta Pharmacol Sin; 2005 Nov; 26(11):1373-81. PubMed ID: 16225761
[TBL] [Abstract][Full Text] [Related]
18. An armed oncolytic herpes simplex virus expressing thrombospondin-1 has an enhanced in vivo antitumor effect against human gastric cancer.
Tsuji T; Nakamori M; Iwahashi M; Nakamura M; Ojima T; Iida T; Katsuda M; Hayata K; Ino Y; Todo T; Yamaue H
Int J Cancer; 2013 Jan; 132(2):485-94. PubMed ID: 22729516
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic activity and antitumor efficacy of PEGylated TNF-related apoptosis-inducing ligand (TRAIL) in a Mia Paca-2 cell-xenografted mouse model.
Byeon HJ; Choi SH; Choi JS; Kim TH; Lee ES; Lee KC; Youn YS
Biomed Pharmacother; 2014 Feb; 68(1):65-9. PubMed ID: 24268811
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis.
Pourgholami MH; Akhter J; Wang L; Lu Y; Morris DL
Cancer Chemother Pharmacol; 2005 May; 55(5):425-32. PubMed ID: 15565325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
